MAT and Sober Living in California

A woman on buprenorphine gets turned away from a house, is told she is “not really sober,” and stops taking the medication that was keeping her alive. That sequence is common enough to be worth writing down: what the medications are, what the law appears to say, and what a residence must do differently — which is less than most operators think.

What MAT is, in plain language

Buprenorphine, methadone and naltrexone are the three medications approved by the FDA to treat opioid use disorder. They “help normalize brain chemistry, by blocking the euphoric effects of alcohol and opioids, relieving physiological cravings, and restoring normal body functions,” they are safe for long-term use “ranging from months to a lifetime,” and they “do not just substitute one drug for another” (SAMHSA).

• Buprenorphine (often as Suboxone) was the first of the three that could be prescribed or dispensed in an ordinary physician office, which is why access widened so quickly (SAMHSA). Practically: a prescription, filled at a pharmacy, taken daily.
• Methadone is a long-acting full opioid agonist and a Schedule II medication (SAMHSA). Practically: dosed at a licensed opioid treatment program, often daily at first, with take-home doses earned over time. This is the one with real logistics attached.
• Naltrexone, including the monthly extended-release injection, is approved for both opioid and alcohol use disorder (SAMHSA). Practically: an injection at a clinic or daily tablets, with no opioid agonist involved.

All three are prescribed by a licensed clinician. None is something a recovery residence prescribes, adjusts, or has any business having an opinion about.

Can a house refuse her?

Many do. Whether they may is a different question, and the honest answer is that federal agencies have taken positions that point strongly against blanket refusals — not that any particular outcome is guaranteed.

On housing: the Department of Justice and HUD have jointly stated that “the term ‘group home’ includes homes occupied by persons in recovery from alcohol or substance abuse, who are persons with disabilities under the Act,” and that the Fair Housing Act treats residents of those homes no differently from residents of other group homes. The same statement notes the Act does not require someone to be in a treatment program to be a person with a disability (DOJ and HUD joint statement on group homes and the Fair Housing Act).

On medication: the Department of Justice states that the Americans with Disabilities Act “protects people in recovery from opioid use disorder (OUD) who are not engaging in illegal drug use, including those who are taking medication prescribed by their doctor,” and that legally prescribed medication taken as directed “is not considered to be current illegal drug use” (ADA.gov). Its longer guidance adds that people in a supervised treatment program are protected and that “it is illegal to discriminate against these individuals based on their treatment for OUD” (DOJ, The ADA and the Opioid Crisis). The DOJ also notes the ADA permits reasonable drug testing aimed at illegal drug use — which is not the same as penalizing a prescription (ADA.gov).

Be careful with that. Which statute reaches which house, and what remedy follows, turns on facts we cannot see from here: how the residence is structured, whether it takes public funding, and what was said and written. Nobody should read this page and conclude a case is won. If a house refuses her over prescribed medication, talk to a fair-housing attorney or legal-aid office and consider a complaint to HUD’s Office of Fair Housing and Equal Opportunity, the DOJ Civil Rights Division, or the California Civil Rights Department. Locally, Inland Counties Legal Services is the legal-aid starting point.

How a non-clinical residence accommodates MAT

This is the part operators overcomplicate. A residence that provides no clinical services does not need a medication program. It needs to stay out of the way, safely.

• Medication is self-managed. She holds her own prescription and takes it as her prescriber directed. Staff do not dispense, administer, hold, count or approve doses, because all of that starts to look like the clinical care an unlicensed residence must not provide.
• Each resident gets her own lockbox. Her medication stays secured in her own space. That protects her supply, protects the house, and ends the argument about medication “lying around.”
• No tapering requirement. Length of treatment is between her and her prescriber, and SAMHSA says people should consult their doctor before discontinuing (SAMHSA).
• Testing that knows the difference. A prescribed medication on a panel is a documented prescription, not a positive. Ask for prescription details at intake precisely so a result is never mistaken for use.
• Privacy. What she takes is health information. It does not belong in a house meeting.

The logistics that actually decide it

For buprenorphine and naltrexone, logistics are usually a pharmacy run and a monthly appointment. For methadone, dosing is often daily at first, so a placement only works if she can physically reach a clinic before work.

The nearest licensed opioid treatment programs to Montclair are Aegis clinics. Aegis Treatment Centers, 1825 E. Thelborn Street, West Covina, (626) 915‑3844 offers methadone, Suboxone and Vivitrol (Pinnacle Treatment). Aegis – Pomona, 1050 N. Garey Avenue, (909) 623‑6391 offers methadone and Suboxone, takes walk-ins and same-day admissions, and accepts Medi‑Cal (Pinnacle Treatment). A third Aegis narcotic treatment program at 125 West F Street in Ontario, (909) 986‑4550, is listed in the county directory as dosing weekdays from 5 a.m. (San Bernardino County Behavioral Health).

Getting there without a car: Foothill Transit Line 480 runs West Covina to Pomona to Montclair Transit Center as a single-seat ride, no transfer (Line 480), and Line 197 and the Silver Streak also link Montclair and Pomona (Line 197, Silver Streak). Adult fare is $1.75 a ride or $60 for 31 days (fares), the transit center also carries Omnitrans and Metrolink (City of Montclair), and Metrolink gives 50% off to holders of a valid California EBT card (Metrolink). A 5 a.m. dosing window against a later first bus is the detail to check before move-in.

Questions to ask a house

• Do you accept methadone, buprenorphine and naltrexone? Name all three. Some houses take one and refuse another.
• Do you require a taper or a maximum dose? Any yes is a clinical decision made by people with no clinical license.
• Who stores medication, and where? Self-managed in her own lockbox, or handed to staff? Ask about take-home doses.
• How do you test, and how do you record a prescription? Ask how a prescription is kept from being logged as a positive.
• Is her clinic reachable on the bus she would actually take? Ask them to name the route.

Where Her Aria stands

We welcome women on medication for opioid use disorder. Medication is self-managed, kept in the resident’s own lockbox, and never dispensed, held or counted by anyone here. We do not require tapering and we do not treat a prescription as a relapse. We also provide no clinical services of any kind, so her prescriber and her clinic remain the only people managing her medication. Her Aria is a women’s recovery residence in Montclair, opening November 2026 with 5 beds, from $950 a month plus a one-time $250 program acceptance fee, no deposits, private pay.

Placing a woman on MAT and want to check the details first? A professional can send a referral or call (909) 817‑1507, and our resources page lists local clinics, county helplines and legal aid. Asking costs nothing.